FDA Inspection
Pharmalab Enterprises, Inc.Pharmalab Enterprises, Inc. – FDA Inspection, Aug 20, 2021
Record Details
This FDA Inspection record concerns Pharmalab Enterprises, Inc., with an inspection on August 20, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pharmalab Enterprises, Inc.
- Inspection Date
- August 20, 2021
- Product Type
- Drugs
View Company Profile
ID · 16da5123-c092-4fcd-a63a-aa9ab871e117
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1149250
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
- 21 CFR 211.166(a)(3)Valid stability test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmalab Enterprises, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 25, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmalab Enterprises, Inc.
- FDA Inspection 948189 - 2015-11-13
- FDA Inspection 819846 - 2013-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.